文献速递心力衰竭与心肌病瓣膜病与结构性心脏病肺血管病与心包/心肌炎

印度妊娠合并心脏病患者的妊娠结局:M-PAC登记研究

Pregnancy outcomes in women with heart disease: the Madras Medical College Pregnancy And Cardiac (M-PAC) Registry from India.
PubMed 文献 · Eur Heart J · 2023-01-01

该前瞻性登记研究纳入印度Tamil Nadu地区1029例妊娠合并心脏病孕妇,评估母婴结局并验证改良WHO(mWHO)分类的适用性。主要心脏不良事件发生率为15.2%,孕产妇死亡率为1.9%,人工心脏瓣膜患者死亡率最高(8.6%)。mWHO分类对主要心脏不良事件和孕产妇死亡的c-statistic分别为0.794和0.796。

要点

  • 妊娠合并心脏病患者主要心脏不良事件发生率为15.2%,心力衰竭最常见(66.0%)。
  • 孕产妇死亡率为1.9%,人工心脏瓣膜患者死亡率最高(8.6%)。
  • mWHO分类对主要心脏不良事件预测的c-statistic为0.794,对孕产妇死亡为0.796。

核心结论

  • 印度妊娠合并心脏病患者孕产妇死亡率较高,死亡风险最高见于人工心脏瓣膜、肺动脉高压和左室收缩功能障碍患者。
  • mWHO分类可能需要在印度进一步调整和验证。

主要发现

  • 60.5%(623/1029)在妊娠期间首次诊断心脏病,风湿性心脏病最常见(42%;433/1029),34.2%(352/1029)合并肺动脉高压。
  • 主要心脏不良事件发生率为15.2%(156/1029;95%CI:13.0-17.5),其中心力衰竭最常见(66.0%;103/156;95%CI:58.0-73.4)。
  • 孕产妇死亡率为1.9%(20/1029;95%CI:1.1-2.8),人工心脏瓣膜患者死亡率最高(8.6%;6/70)。
  • 活产率为91.2%(938/1029;95%CI:89.3-92.8),不良胎儿事件发生率为33.7%(347/1029;95%CI:30.8-36.7)。

关键数值与推荐

  • 左室收缩功能障碍、人工心脏瓣膜、重度二尖瓣狭窄、肺动脉高压和妊娠期首次诊断心脏病是主要心脏不良事件的独立预测因素。
  • mWHO分类预测主要心脏不良事件的c-statistic为0.794(95%CI:0.763-0.826),预测孕产妇死亡的c-statistic为0.796(95%CI:0.732-0.860)。

临床怎么用

  • 对妊娠合并心脏病患者应关注人工心脏瓣膜、肺动脉高压和左室收缩功能障碍等高危因素,加强监测与管理。
  • mWHO分类可用于风险分层,但在印度人群中可能需要进一步调整和验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS: To evaluate the feto-maternal outcome, identify the adverse outcome predictors and test the applicability of modified WHO (mWHO) classification in pregnant women with heart disease (PWWHD) from Tamil Nadu, India. METHODS AND RESULTS: One thousand and five pregnant women (mean age: 26.04 ± 4.2) with 1029 consecutive pregnancies were prospectively enrolled from July 2016 to December 2019 in the Madras medical college pregnancy and cardiac (M-PAC) registry. Majority (60.5%; 623/1029) had heart disease (HD) diagnosed for the first time during pregnancy. Rheumatic HD (42%; 433/1029) was most common. One third (34.2%; 352/1029) had pulmonary hypertension (PH). Maternal mortality and composite maternal cardiac events (MCEs) were the primary outcomes. Secondary outcomes were foetal loss and composite adverse foetal events (AFEs). MCEs occurred in 15.2% (156/1029; 95% CI: 13.0-17.5) pregnancies. Heart failure was the most common MCE (66.0%; 103/156; 95% CI: 58.0-73.4). Maternal mortality was 1.9% (20/1029; 95% CI: 1.1-2.8), with highest rates in patients with prosthetic heart valves (PHVs) (8.6%; 6/70). Left ventricular systolic dysfunction (LVSD), PHVs, severe mitral stenosis, PH and current pregnancy diagnosis of HD were independent predictors of MCE. The c-statistic of mWHO classification for predicting MCE and maternal death were 0.794 (95% CI: 0.763-0.826) and 0.796 (95% CI: 0.732-0.860). 91.2% (938/1029; 95% CI: 89.392.8) of pregnancies resulted in live births. 33.7% (347/1029; 95% CI: 30.8-36.7) of pregnancies reported AFEs. CONCLUSION: Maternal mortality is high in PWWHD from India. Highest death rates occurred in women with PHVs, PH and LVSD. The mWHO classification for risk stratification may require further adaptation and validation in India.

来源:Eur Heart J,查看原文。版权归原作者所有。

引用

  1. Justin Paul G, Anne Princy S, Anju S, et al. Pregnancy outcomes in women with heart disease: the Madras Medical College Pregnancy And Cardiac (M-PAC) Registry from India. Eur Heart J. 2023. PMID: 37395726. doi:10.1093/eurheartj/ehad003

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。